Global Health and Population Division, FHI 360, Durham, NC 27701, USA.
Department of Population Health Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Int J Environ Res Public Health. 2024 Mar 21;21(3):376. doi: 10.3390/ijerph21030376.
PrEP, a biomedical HIV prevention option, continues to be underutilized among transgender women who could benefit from sustained use, especially women of color and those who identify as Latina and/or reside in the southeastern US.
We explored the barriers and facilitators experienced by transgender women who live in Florida regarding accessing, using, and/or staying on PrEP.
In-depth interviews and focus groups were conducted in either Spanish or English with adult transgender women living in Florida (N = 22). The interviews were audio-recorded, transcribed, and coded in ATLAS.ti using thematic analyses.
The mean age of the participants was 42.2 years. Among the participants, 73% were Hispanic/Latina, 59% were foreign-born, and approximately one-third were living with HIV (but had past experience with PrEP). Transgender women cited the following barriers to accessing or considering PrEP: (1) costs and benefits of PrEP use; (2) under-representation in clinical trials resulting in unknown or misinformation regarding PrEP side effects; (3) chronic poverty; and (4) trauma and discrimination. Other stressors, such as behavioral healthcare needs, were identified.
Our analysis revealed interlocking systems of oppression like transphobia, discrimination, and misgendering, which were common barriers experienced by our participants. These synergistically epidemic (i.e., syndemic) barriers contributed to their feelings of being systematically excluded in social spaces, research, public health planning and policies, laws, and social programs related to PrEP. These structural barriers are impediments to HIV preventive care but also act as a source of stress that contributes to mental health problems, financial vulnerability, substance abuse, and other deleterious health outcomes.
暴露前预防(PrEP)是一种生物医学艾滋病预防选择,但在可能受益于持续使用 PrEP 的跨性别女性中,其使用率仍然较低,尤其是有色人种女性,以及自认为是拉丁裔和/或居住在美国东南部的女性。
我们探讨了居住在佛罗里达州的跨性别女性在获得、使用和/或坚持使用 PrEP 方面所经历的障碍和促进因素。
我们以西班牙语或英语对居住在佛罗里达州的成年跨性别女性进行了深入访谈和焦点小组讨论(N=22)。访谈以音频形式记录,使用 ATLAS.ti 进行转录和编码,并采用主题分析进行分析。
参与者的平均年龄为 42.2 岁。在参与者中,73%是西班牙裔/拉丁裔,59%是外国出生,大约三分之一的人感染了艾滋病毒(但有过 PrEP 治疗经历)。跨性别女性在获得或考虑使用 PrEP 时遇到了以下障碍:(1)PrEP 使用的成本和收益;(2)临床试验代表性不足,导致对 PrEP 副作用的了解不足或存在误解;(3)长期贫困;(4)创伤和歧视。还确定了其他压力源,如行为保健需求。
我们的分析揭示了跨性别恐惧症、歧视和错误性别认同等相互交织的压迫系统,这些都是我们参与者共同面临的障碍。这些协同作用的(即综合征)障碍导致他们在与 PrEP 相关的社会空间、研究、公共卫生规划和政策、法律和社会项目中感到被系统地排斥。这些结构性障碍不仅是艾滋病毒预防护理的障碍,也是导致心理健康问题、经济脆弱性、药物滥用和其他不良健康后果的压力源。